SNN: Smith & Nephew plc - Summary | Jitta

Smith & Nephew plc

NYSE:SNN

Price
$43.42
Loss Chance
45.5%
7.50JITTA SCORE
40.12%Above Jitta Line
Jitta Ranking
55 / 823
1,018 / 4,769
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (43)
Recent Business Performance (70)
Financial Strength (93)
Return to Shareholders (83)
Competitive Advantage (75)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
7.50
40.12%
2.22
0.67%
Healthcare Equipment
5.20
65.72%
8.10
31.47%
0.70
100.00%
COMPANY DESCRIPTION
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. Additionally, it offers meniscal repair system. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.